DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment

 

MRI Homepage

Elekta to add functional imaging capabilities and take more time to validate MR-linac system Expects CE approval in first half of 2018

Aspect Imaging scores CE mark for its Embrace Neonatal MR system Already in use in Israel

Updated guidelines recommend use of S-ICDs for patients with ventricular arrhythmia Call to action for physicians

Study cautions against trust in MR results for axial spondyloarthritis MR scans are prone to produce positive results for axSpA in healthy individuals

Mallinckrodt Institute of Radiology installs first Siemens MAGNETOM Vida in the US First Siemens MR scanner to carry BioMatrix technology

MR study shows how different football positions impact brain damage First time DTI and fMRI used in conjunction

Action star Chuck Norris, wife Gena, sue eleven organizations over gadolinium Allege MR contrast agent 'nearly killed her'

Swedish researchers map brains of patients with prosthetic limbs using 7T MR Progress in pursuit of fake limbs that feel real

Using functional MR to predict suicidal tendencies Revealing alterations in brain patterns in response to concepts such as death, cruelty, and trouble

Getting the most from your MR coils As these systems get more complicated, so does repairing them

Researchers continue to look
for brain-based biomarkers

New guidelines advise against the use of brain imaging to diagnose chronic pain

por Lauren Dubinsky , Senior Reporter
A task force of researchers from around the world released new guidelines that recommend against the use of brain imaging to diagnose chronic pain.

With current imaging technology it’s impossible to determine whether a patient is experiencing chronic pain, according to Dr. Karen Davis, pain researcher at the Krembil Research Institute in Toronto, who led the task force. She argued that only the patient can provide that information, since pain is subjective.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory



Data from the Institute of Medicine of The National Academies revealed that 100 million Americans suffer from chronic pain. That’s more than the combined incidence of diabetes, coronary heart disease, stroke and cancer.

“Currently, physicians use a variety of approaches to decide on chronic pain treatments that relate to many medical and practical issues,” Davis told HCB News. “The method that is used is effective for some patients but not for many others.”

Physicians take into consideration the severity of the pain, other factors that accompany the pain, such as inflammation, other medical conditions the patient may have that prevent them from using some classes of drugs, the side effects of treatment, and what would be tolerable for the patient.

Recent advancements in brain imaging have led to a greater understanding of acute and chronic pain. That prompted a search for brain-based biomarkers for pain in order to offer patients more personalized treatment options.

Brain imaging is also in high demand among the legal community for use as a “lie detector” for chronic pain. Davis refers to that practice as inappropriate and unethical because pain varies between individuals and even within an individual at different times.

The new guidelines, which are published in the journal Nature Review: Neurology, state that any brain-based biomarkers should only be used as an adjunct to subjective reports of pain even if testing is improved and valid protocols are developed.

Davis and her team are working toward finding biomarkers for chronic pain to help provide more personalized treatment. The task force hopes the guidelines will be used by health care systems, governments, and legal policy makers as a blueprint for moving forward with research.

“Through brain imaging, we may be able to find particular features of the brain in some patients that are present when a particular treatment is effective, and other features that are present when that treatment is not,” said Davis. “Then, we would be able to match the patient to treatment.”

Back to HCB News
  Pages: 1

MRI Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2017 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS